908 Devices (MASS) Amortization of Deferred Charges (2026)
908 Devices' (MASS) quarterly Amortization of Deferred Charges came in at $10000.0 in Q1 2026.
908 Devices (MASS) Amortization of Deferred Charges (2026) Analysis & Trends
908 Devices (MASS) has 1 years of Amortization of Deferred Charges data on file, last reported at $10000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.00 Bn | 175.71 Bn | 6.27 Bn |
| 2 | Stryker | 128.69 Bn | 125.81 Bn | 3.81 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.97 Bn | 44.30 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.00 Bn | 1.98 Bn |
| 7 | Dexcom | 28.21 Bn | 27.09 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn |
| 10 | 908 Devices | 257.73 Mn | 145.99 Mn | 6.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |